Pinnacle Associates’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-6,862
Closed -$228K 768
2022
Q2
$228K Sell
6,862
-1,075
-14% -$45.7K 0.01% 675
2022
Q1
$572K Buy
7,937
+5,459
+220% +$393K 0.01% 525
2021
Q4
$228K Buy
2,478
+640
+35% +$76.5K ﹤0.01% 736
2021
Q3
$233K Sell
1,838
-323
-15% -$47K ﹤0.01% 698
2021
Q2
$359K Buy
2,161
+665
+44% +$108K 0.01% 606
2021
Q1
$272K Buy
+1,496
New +$347K 0.01% 642

Other funds holding TDOC

Pinnacle Associates's TDOC Position: Q3 2022 in Review

Pinnacle Associates sold out of Teladoc Health (TDOC) in Q3 2022, closing a stake of 6,862 shares — an estimated $228K sold.

Pinnacle Associates first reported a position in TDOC in Q1 2021 and held it in 6 quarters. The position peaked at $572K in Q1 2022. 483 funds tracked by Wall St. Rank hold TDOC as of Q3 2022.

  • Pinnacle Associates reported no remaining Teladoc Health position as of Q3 2022 after selling out during the quarter.
  • Pinnacle Associates sold 6,862 Teladoc Health shares in Q3 2022, an estimated $228K.
  • Pinnacle Associates first reported a position in Teladoc Health in Q1 2021 and held it in 6 quarters.
  • Pinnacle Associates's Teladoc Health position peaked at $572K in Q1 2022.
  • 483 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2022.

Based on Pinnacle Associates's 13F filing for Q3 2022, filed 1 Nov 2022.